← All trials
NCT00213031
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2000
- Primary completion
- —
- Completion date
- Dec 1, 2001
- First posted
- —
- Last posted
- —
- Enrollment
- 165
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- Population CouncilLead sponsor
- Chiang Rai District Health OfficeCollaborator
- Population CouncilOverall official - principal investigator
- Bill and Melinda Gates FoundationCollaborator
- National Center for Infectious DiseasesCollaborator
- Chiangrai Prachanukroh HospitalCollaborator
- Government of ThailandCollaborator
- Centers for Disease Control and Prevention (CDC)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.